FN2 Earnings Intelligence
Lam Research Corporation financials
Lam Research Corporation (LRCX) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 6/26/2022 | 6/25/2023 | 6/30/2024 | 6/29/2025 | 6/28/2026 | 6/29/2026 est. | 6/28/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $3,522 | $5,337.1 | $5,847.9 | $6,390.7 | $5,579.2 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $17,227 | $17,428.5 | $14,905.4 | $18,435.6 | $23,232.7 | $23,195.8 | $34,798.7 |
| % Growth | 17.8% | 1.2% | -14.5% | 23.7% | 26.0% | 25.8% | 50.0% |
| Gross Profit | $7,871.8 | $7,776.9 | $7,052.8 | $8,979.1 | $11,725.3 | - | - |
| % Margin | 45.7% | 44.6% | 47.3% | 48.7% | 50.5% | - | - |
| EBITDA | $5,715.6 | $5,517.3 | $4,623.6 | $6,287.2 | $8,641.3 | - | - |
| % Margin | 33.2% | 31.7% | 31.0% | 34.1% | 37.2% | - | - |
| Net Income | $4,605.3 | $4,510.9 | $3,827.8 | $5,358.2 | $7,265.4 | - | - |
| % Margin | 26.7% | 25.9% | 25.7% | 29.1% | 31.3% | - | - |
| Diluted EPS | $32.75 | $33.21 | $29.00 | $4.15 | $5.76 | $5.70 | $9.49 |
| % Growth | 21.7% | 1.4% | -12.7% | -85.7% | 38.8% | 37.2% | 66.6% |
| Operating Cash Flow | $3,099.7 | $5,178.9 | $4,652.3 | $6,173.3 | $5,857.7 | - | - |
| CapEx | $546 | $501.6 | $396.7 | $759.2 | $966.4 | - | - |
| Free Cash Flow | $2,553.6 | $4,677.4 | $4,255.6 | $5,414.1 | $4,891.3 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 6/26/2022 | 6/25/2023 | 6/30/2024 | 6/29/2025 | 6/28/2026 | 6/29/2026 est. | 6/28/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $17,227 | $17,428.5 | $14,905.4 | $18,435.6 | $23,232.7 | $23,195.8 | $34,798.7 |
| Gross Profit | $7,871.8 | $7,776.9 | $7,052.8 | $8,979.1 | $11,725.3 | - | - |
| EBITDA | $5,715.6 | $5,517.3 | $4,623.6 | $6,287.2 | $8,641.3 | - | - |
| Net Income | $4,605.3 | $4,510.9 | $3,827.8 | $5,358.2 | $7,265.4 | - | - |
| Diluted EPS | $32.75 | $33.21 | $29.00 | $4.15 | $5.76 | $5.70 | $9.49 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 6/26/2022 | 6/25/2023 | 6/30/2024 | 6/29/2025 | 6/28/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $3,522 | $5,337.1 | $5,847.9 | $6,390.7 | $5,579.2 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $4,962.5 | $4,964.9 | $4,466 | $3,719.7 | $3,721.9 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 6/26/2022 | 6/25/2023 | 6/30/2024 | 6/29/2025 | 6/28/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $3,099.7 | $5,178.9 | $4,652.3 | $6,173.3 | $5,857.7 |
| Capital Expenditure | $546 | $501.6 | $396.7 | $759.2 | $966.4 |
| Free Cash Flow | $2,553.6 | $4,677.4 | $4,255.6 | $5,414.1 | $4,891.3 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 6/26/2022 | 6/25/2023 | 6/30/2024 | 6/29/2025 | 6/28/2026 |
|---|---|---|---|---|---|
| Revenue Growth | 17.8% | 1.2% | -14.5% | 23.7% | 26.0% |
| Gross Margin | 45.7% | 44.6% | 47.3% | 48.7% | 50.5% |
| EBITDA Margin | 33.2% | 31.7% | 31.0% | 34.1% | 37.2% |
| Net Margin | 26.7% | 25.9% | 25.7% | 29.1% | 31.3% |
| FCF Margin | 14.8% | 26.8% | 28.6% | 29.4% | 21.1% |
| Diluted EPS Growth | 21.7% | 1.4% | -12.7% | -85.7% | 38.8% |